logo
  

Lilly To Supply 388,000 Doses Of Etesevimab To U.S. For Treatment Of COVID-19

Eli Lilly and Co.(LLY) said that it will supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19 Additional doses of etesevimab will be paired with existing bamlanivimab purchased by the U.S. government.

As part of the agreement, Lilly will supply 388,000 doses of etesevimab to complement doses of bamlanivimab previously purchased by the U.S. government, with approximately 200,000 doses expected to ship third-quarter 2021 and the remaining to be shipped in the fourth-quarter.

Lilly expects the transaction will generate approximately $330 million in revenue in the second half of 2021.

Bamlanivimab and etesevimab together are authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death.

Bamlanivimab and etesevimab are not authorized for use in states, territories, and US jurisdictions in which the combined frequency of variants resistant to bamlanivimab and etesevimab exceeds 5%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
San Jose, California -based Demaiz Inc., doing business as Mex-tamale Foods, is recalling around 20,759 pounds of pork and beef tamales citing misbranding and undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The beef and pork tamale items produced between September 20 to October 14, 2021 contains sesame seeds, an allergen. McDonald's says equal pay for women is just the beginning, while conforming that the fast-food giant pays women globally 99.85 cents on the dollar for similar work, taking into account legitimate pay drivers such as level, location, experience, and performance. The company added that it is on track to close that identified gap in 2022. Verizon Communications Inc. (VZ) said, on an adjusted basis, its third-quarter earnings per share rose 12.8 percent from a year ago. The company said its earnings were highlighted by revenue and customer growth as more than one in four Consumer wireless phone customers now have a 5G-capable device. The...
Follow RTT